Restart Life Sciences Corp.
Restart Life Sciences Corp. (NMLSF) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001689231 · NMLSF · OTC · as of Jun 15, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001689231 · Updated hourly · Not investment advice
Latest Key Filings
No recent filings
No recent filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Restart Life Sciences Corp. (OTC: NMLSF) has submitted 3 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2008. As a Healthcare sector company with CIK 0001689231, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Restart Life Sciences Corp.'s most comprehensive regulatory disclosure. The most recent Restart Life Sciences Corp. 10-K was filed on — for fiscal year ending —. Historical NMLSF 10-K annual reports are available from 2016 through —.
Investors researching Restart Life Sciences Corp. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
NMLSF SEC Filings · 8 questionsRestart Life Sciences Corp. (NMLSF) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 3 filings and access original documents at no cost. Restart Life Sciences Corp.'s CIK is 0001689231.